Form 8-K - Current report:
SEC Accession No. 0001104659-25-005594
Filing Date
2025-01-23
Accepted
2025-01-23 16:01:24
Documents
14
Period of Report
2025-01-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm254188d1_8k.htm   iXBRL 8-K 27973
2 EXHIBIT 10.1 tm254188d1_ex10-1.htm EX-10.1 9899
  Complete submission text file 0001104659-25-005594.txt   215225

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA immu-20250121.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20250121_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20250121_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm254188d1_8k_htm.xml XML 3688
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39580 | Film No.: 25550056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)